LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype
- DOI
- 10.1002/ctm2.70134
- Published
- 2024-12
- Container
- Clinical and Translational Medicine
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/ctm2.70134,
title = {LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype},
author = {Nadia Cobo‐Vuilleumier and Silvia Rodríguez‐Fernandez and Livia López‐Noriega and Petra I. Lorenzo and Jaime M. Franco and Christian C. Lachaud and Eugenia Martin Vazquez and Raquel Araujo Legido and Akaitz Dorronsoro and Raul López‐Férnandez‐Sobrino and Beatriz Fernández‐Santos and Carmen Espejo Serrano and Daniel Salas‐Lloret and Nila van Overbeek and Mireia Ramos‐Rodriguez and Carmen Mateo‐Rodríguez and Lucia Hidalgo and Sandra Marin‐Canas and Rita Nano and Ana I. Arroba and Antonio Campos Caro and Alfred CO Vertegaal and Alejandro Martín‐Montalvo and Franz Martín and Manuel Aguilar‐Diosdado and Lorenzo Piemonti and Lorenzo Pasquali and Roman González Prieto and Maria Isabel García Sánchez and Decio L. Eizirik and Maria Asuncion Martínez‐Brocca and Marta Vives‐Pi and Benoit R. Gauthier},
year = {2024},
journal = {Clinical and Translational Medicine},
doi = {10.1002/ctm2.70134},
url = {https://doi.org/10.1002/ctm2.70134}
}RIS
TY - JOUR TI - LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype AU - Nadia Cobo‐Vuilleumier AU - Silvia Rodríguez‐Fernandez AU - Livia López‐Noriega AU - Petra I. Lorenzo AU - Jaime M. Franco AU - Christian C. Lachaud AU - Eugenia Martin Vazquez AU - Raquel Araujo Legido AU - Akaitz Dorronsoro AU - Raul López‐Férnandez‐Sobrino AU - Beatriz Fernández‐Santos AU - Carmen Espejo Serrano AU - Daniel Salas‐Lloret AU - Nila van Overbeek AU - Mireia Ramos‐Rodriguez AU - Carmen Mateo‐Rodríguez AU - Lucia Hidalgo AU - Sandra Marin‐Canas AU - Rita Nano AU - Ana I. Arroba AU - Antonio Campos Caro AU - Alfred CO Vertegaal AU - Alejandro Martín‐Montalvo AU - Franz Martín AU - Manuel Aguilar‐Diosdado AU - Lorenzo Piemonti AU - Lorenzo Pasquali AU - Roman González Prieto AU - Maria Isabel García Sánchez AU - Decio L. Eizirik AU - Maria Asuncion Martínez‐Brocca AU - Marta Vives‐Pi AU - Benoit R. Gauthier PY - 2024 JO - Clinical and Translational Medicine DO - 10.1002/ctm2.70134 UR - https://doi.org/10.1002/ctm2.70134 ER -
APA
Cobo‐Vuilleumier, N., Rodríguez‐Fernandez, S., López‐Noriega, L., Lorenzo, P. I., Franco, J. M., Lachaud, C. C., Vazquez, E. M., Legido, R. A., Dorronsoro, A., López‐Férnandez‐Sobrino, R., Fernández‐Santos, B., Serrano, C. E., Salas‐Lloret, D., Overbeek, N. V., Ramos‐Rodriguez, M., Mateo‐Rodríguez, C., Hidalgo, L., Marin‐Canas, S., Nano, R., Arroba, A. I., Caro, A. C., Vertegaal, A. C., Martín‐Montalvo, A., Martín, F., Aguilar‐Diosdado, M., Piemonti, L., Pasquali, L., Prieto, R. G., Sánchez, M. I. G., Eizirik, D. L., Martínez‐Brocca, M. A., Vives‐Pi, M., & Gauthier, B. R. (2024). LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70134
Source records
- crossref · retrieved 2026-09-27T04:24:55.367Z